How India's largest ePharmacy is building an in-house quick-commerce engine across cities and why moving medicines in under an hour is far more complicated than it looks
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/c4NTo3D
via IFTTT
-
India's Syngene International has agreed to acquire its first biologics facility in the U.S. from Emergent Manufacturing for $36.5 milli...
-
The establishment inspection report (EIR) was issued after the last inspection of the facility conducted from October 17-29, 2022, the compa...
-
The Indian Council of Medical Research has licensed three new biomedical technologies. These innovations aim to advance cancer treatment and...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2026
(641)
-
▼
October
(13)
- Ayush services sector supports 1.76 million liveli...
- The 30-Minute Medicine Problem
- Drug panel rejects child images on cough syrup lab...
- Lord’s Mark strengthens UK and UK allied market st...
- Centre may seek legal view on licensing of sterile...
- Ayush services sector supports 1.76 million liveli...
- Wall Street’s $10 billion India hospital bet spark...
- Robotic surgery gains rapid ground in India, Delhi...
- Maharashtra FDA cancels Cipla's Pune warehouse lic...
- India has biotech talent and know-how, but funding...
- ‘India’s biotech ecosystem holds tremendous promis...
- Karnataka flags 52x mark-up on cancer drugs, seeks...
- Rasayan Labs launches AI-native drug discovery pla...
-
▼
October
(13)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment